Following news from Pfizer on Friday, several pharmaceutical companies were among the significant losers on Friday. BioNTech was one of them.
Biontech SE is a German biotechnology company based in Mainz that has been listed on the stock exchange since the end of 2019. It is focused on the development and manufacture of active immunotherapies for a patient-specific approach to the treatment of cancer and other serious diseases.
For more updates, follow us on Twitter:@JRC_Capital